A biopharmaceutical company developing prophylactic and therapeutic application of messenger RNA, which can be used to develop vaccines. It was founded in 2000 and is located in Tübingen, Germany.
| Business Model | Commerce |
|---|---|
| Legal Name | CureVac N.V. |
| Company Operating Status | Active |
| Full Address | 250 Summer St 3rd Fl Boston, MA 02210, USA |
| Previous Name | CureVac B.V. |
| Stock Symbol | CVAC |
| Ticker Symbol | CVAC |
| Wellfound ID | curevac |
| Wikidata ID | Q1144473 |
Email and phone for CureVac are available to signed-in members of CliffBio.
Sign in to view